{"topic_id":"EU_2020_354_entry_14_cystine_stones","category":"eu","context":"EU Reg 2020/354 Part B Entry 14 — `Reduction of cystine stones formation`\n\n**Species**: Dogs\n\n**Purpose (essential nutritional characteristics)**: Reduction of cystine stones formation — Urine alkalinising properties and crude protein ≤ 160 g/kg complete feed with a moisture content of 12 % (2) Or Proteins selected for a limited cystine and cysteine content (e.g. casein, pea protein, soy protein) and crude protein ≤ 220 g/kg complete feed with a moisture content of 12 % (2)\n\n**Duration of use**: Initially up to 6 month\n\n**Source**: EU Reg 2020/354 Part B (consolidated text per EUR-Lex CELEX:02020R0354, version 2025-04-22). Entry 14 is part of the 44 PARNUT entries in Part B (range 10-72). Cross-references: AAFCO nutrition profiles for chronic kidney disease, cardiac disease, dermatological conditions. FEDIAF nutritional guidelines 2025 provide complementary guidance but do not authorize therapeutic claims — EU 2020/354 is required for products marketed with PARNUT claims.\n\n**Notes**: This entry is part of the 44-entry block (10-30 + 50-72). Entries 31-49 are not used in the current consolidated text (numbering jumps from 30 to 50). Always consult official EUR-Lex consolidated 2020/354 text when preparing EU-market petitions for products covered by Entry 14.\n","sources":["reg_2020_354_consolidated_20250422.txt"],"tokens_estimated":256,"generated_at":"2026-07-18","tip":"Use /api/v1/topics to discover more topics. /api/v1/nutrient for precise single-point queries. /api/v1/cross_compare for 2-3 standard comparisons."}